{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T18:47:50Z","timestamp":1762368470422,"version":"build-2065373602"},"reference-count":20,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,9]],"date-time":"2025-07-09T00:00:00Z","timestamp":1752019200000},"content-version":"vor","delay-in-days":8,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004480","name":"Natural Science Foundation of Shanxi Province","doi-asserted-by":"publisher","award":["201901D111426"],"award-info":[{"award-number":["201901D111426"]}],"id":[{"id":"10.13039\/501100004480","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer\/Radioth\u00e9rapie"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.canrad.2025.104671","type":"journal-article","created":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T16:38:45Z","timestamp":1752597525000},"page":"104671","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Neoadjuvant chemoradiotherapy for oesophageal cancer: Primary tumour\/lymph node regression inconsistency and prognostic value analysis"],"prefix":"10.1016","volume":"29","author":[{"given":"Zhang","family":"Xiaoyuan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wang","family":"Yong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanbin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.canrad.2025.104671_bib0105","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1016\/S0140-6736(17)31462-9","article-title":"Oesophageal cancer","volume":"390","author":"Lagergren","year":"2017","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.canrad.2025.104671_bib0110","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1002\/ijc.34301","article-title":"Esophageal cancer in China: practice and research in the new era","volume":"152","author":"Zhu","year":"2023","journal-title":"Int J Cancer"},{"issue":"8","key":"10.1016\/j.canrad.2025.104671_bib0115","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1007\/s00268-022-06568-z","article-title":"Evaluation of neoadjuvant chemoradiotherapy followed by surgery for borderline resectable esophageal squamous cell carcinoma","volume":"46","author":"Hirohata","year":"2022","journal-title":"World J Surg"},{"issue":"27","key":"10.1016\/j.canrad.2025.104671_bib0120","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.1200\/JCO.2018.79.1483","article-title":"Neoadjuvant chemoradiotherapy followed by surgery versus surgery alone for locally advanced squamous cell carcinoma of the esophagus (NEOCRTEC5010): a phase III multicenter, randomized, open-label clinical trial","volume":"36","author":"Yang","year":"2018","journal-title":"J Clin Oncol"},{"issue":"22","key":"10.1016\/j.canrad.2025.104671_bib0125","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1056\/NEJMoa1112088","article-title":"Preoperative chemoradiotherapy for esophageal or junctional cancer","volume":"366","author":"van Hagen","year":"2012","journal-title":"New Engl J Med"},{"issue":"9","key":"10.1016\/j.canrad.2025.104671_bib0130","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/S1470-2045(15)00040-6","article-title":"Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial","volume":"16","author":"Shapiro","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.canrad.2025.104671_bib0135","doi-asserted-by":"crossref","first-page":"853922","DOI":"10.3389\/fimmu.2022.853922","article-title":"Tislelizumab plus chemotherapy sequential neoadjuvant therapy for non-cCR Patients after neoadjuvant chemoradiotherapy in locally advanced esophageal squamous cell carcinoma (ETNT): an exploratory study","volume":"13","author":"He","year":"2022","journal-title":"Front Immunol"},{"issue":"13","key":"10.1016\/j.canrad.2025.104671_bib0140","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1056\/NEJMoa2032125","article-title":"Adjuvant nivolumab in resected esophageal or gastroesophageal junction cancer","volume":"384","author":"Kelly","year":"2021","journal-title":"New Engl J Med"},{"key":"10.1016\/j.canrad.2025.104671_bib0145","doi-asserted-by":"crossref","first-page":"7771","DOI":"10.2147\/CMAR.S329687","article-title":"A Survival prediction nomogram for esophageal squamous cell carcinoma treated with neoadjuvant chemoradiotherapy followed by surgery","volume":"13","author":"Ding","year":"2021","journal-title":"Cancer Manag Res"},{"issue":"5","key":"10.1016\/j.canrad.2025.104671_bib0150","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.surg.2010.02.016","article-title":"Utility of response evaluation to neo-adjuvant chemotherapy by (18F)-fluorodeoxyglucose-positron emission tomography in locally advanced esophageal squamous cell carcinoma","volume":"148","author":"Makino","year":"2010","journal-title":"Surgery"},{"key":"10.1016\/j.canrad.2025.104671_bib0155","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1245\/s10434-014-4299-9","article-title":"Prognostic significance of (18F)-fluorodeoxyglucose positron emission tomography (FDG-PET)-positive lymph nodes following neoadjuvant chemotherapy and surgery for resectable thoracic esophageal squamous cell carcinoma","volume":"22","author":"Yasuda","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.canrad.2025.104671_bib0160","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.surg.2008.06.026","article-title":"Use of (18F)-fluorodeoxyglucose-positron emission tomography to evaluate responses to neoadjuvant chemotherapy for primary tumor and lymph node metastasis in esophageal squamous cell carcinoma","volume":"144","author":"Makino","year":"2008","journal-title":"Surgery"},{"issue":"7","key":"10.1016\/j.canrad.2025.104671_bib0165","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1002\/cncr.11660","article-title":"Histomorphology and grading of regression in gastric carcinoma treated with neoadjuvant chemotherapy","volume":"98","author":"Becker","year":"2003","journal-title":"Cancer"},{"issue":"12","key":"10.1016\/j.canrad.2025.104671_bib0170","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1038\/modpathol.2009.123","article-title":"Prognostic significance of histopathological tumor regression after neoadjuvant chemotherapy in esophageal adenocarcinomas","volume":"22","author":"Langer","year":"2009","journal-title":"Modern Pathol"},{"key":"10.1016\/j.canrad.2025.104671_bib0175","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1309\/CCR3QN4874YJDJJ7","article-title":"Histopathologic examination and reporting of esophageal carcinomas following preoperative neoadjuvant therapy: practical guidelines and current issues","volume":"129","author":"Chang","year":"2008","journal-title":"Am J Clin Pathol"},{"issue":"6","key":"10.1016\/j.canrad.2025.104671_bib0180","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1016\/j.jtcvs.2020.09.042","article-title":"Residual tumor characteristics of esophageal squamous cell carcinoma after neoadjuvant chemoradiotherapy","volume":"162","author":"Tang","year":"2021","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"1","key":"10.1016\/j.canrad.2025.104671_bib0185","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.ejso.2016.05.036","article-title":"Prognosis of patients with esophageal squamous cell carcinoma who achieve major histopathological response after neoadjuvant chemoradiotherapy","volume":"43","author":"Chao","year":"2017","journal-title":"Eur J Surg Oncol"},{"issue":"8","key":"10.1016\/j.canrad.2025.104671_bib0190","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1245\/s10434-010-0995-2","article-title":"Histological regression of squamous esophageal carcinoma assessed by percentage of residual viable cells after neoadjuvant chemoradiation is an important prognostic factor","volume":"17","author":"Tong","year":"2010","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.canrad.2025.104671_bib0195","doi-asserted-by":"crossref","first-page":"doab021","DOI":"10.1093\/dote\/doab021","article-title":"Prognostic relevance of lymph node regression on survival in esophageal cancer: a systematic review and meta-analysis","volume":"35","author":"Hagens","year":"2022","journal-title":"Dis Esophagus"},{"issue":"2","key":"10.1016\/j.canrad.2025.104671_bib0200","doi-asserted-by":"crossref","first-page":"656","DOI":"10.21037\/gs-20-686","article-title":"Treatment response correlation between primary tumor and axillary lymph nodes after neoadjuvant therapy in breast cancer: a retrospective study based on real-world data","volume":"10","author":"Wang","year":"2021","journal-title":"Gland Surg"}],"container-title":["Cancer\/Radioth\u00e9rapie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321825000873?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321825000873?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T18:39:57Z","timestamp":1762367997000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1278321825000873"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":20,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S1278321825000873"],"URL":"https:\/\/doi.org\/10.1016\/j.canrad.2025.104671","relation":{},"ISSN":["1278-3218"],"issn-type":[{"type":"print","value":"1278-3218"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neoadjuvant chemoradiotherapy for oesophageal cancer: Primary tumour\/lymph node regression inconsistency and prognostic value analysis","name":"articletitle","label":"Article Title"},{"value":"Cancer\/Radioth\u00e9rapie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canrad.2025.104671","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Masson SAS on behalf of Soci\u00e9t\u00e9 fran\u00e7aise de radioth\u00e9rapie oncologique (SFRO).","name":"copyright","label":"Copyright"}],"article-number":"104671"}}